Granulocytic Sarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-09-19
Clinical Trial Update: CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
A Phase 2 clinical trial evaluating CPI-613 (devimistat) in combination with metformin for relapsed or refractory acute myeloid leukemia has…